Pflug Koory LLC Sells 350 Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Pflug Koory LLC trimmed its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 4.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,930 shares of the medical instruments supplier’s stock after selling 350 shares during the quarter. Pflug Koory LLC’s holdings in DENTSPLY SIRONA were worth $463,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of XRAY. Geode Capital Management LLC raised its stake in DENTSPLY SIRONA by 6.6% in the 4th quarter. Geode Capital Management LLC now owns 2,997,698 shares of the medical instruments supplier’s stock worth $111,355,000 after purchasing an additional 185,780 shares in the last quarter. FMR LLC raised its stake in DENTSPLY SIRONA by 19.0% in the 4th quarter. FMR LLC now owns 1,218,174 shares of the medical instruments supplier’s stock worth $45,329,000 after purchasing an additional 194,701 shares in the last quarter. Mercer Global Advisors Inc. ADV acquired a new stake in DENTSPLY SIRONA in the 1st quarter worth about $219,000. Retirement Systems of Alabama raised its stake in DENTSPLY SIRONA by 1.1% in the 1st quarter. Retirement Systems of Alabama now owns 103,628 shares of the medical instruments supplier’s stock worth $5,139,000 after purchasing an additional 1,092 shares in the last quarter. Finally, Raymond James Trust N.A. acquired a new stake in DENTSPLY SIRONA in the 1st quarter worth about $268,000. Institutional investors and hedge funds own 97.06% of the company’s stock.

Several brokerages have weighed in on XRAY. Wellington Shields upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research note on Friday, August 2nd. Wolfe Research began coverage on shares of DENTSPLY SIRONA in a research note on Thursday, May 30th. They issued a “peer perform” rating for the company. Barrington Research reiterated a “buy” rating and issued a $63.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Evercore ISI initiated coverage on shares of DENTSPLY SIRONA in a research report on Friday, July 26th. They issued an “in-line” rating for the company. Finally, Zacks Investment Research cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research report on Monday, May 27th. Nine investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $54.57.



In related news, Director Betsy D. Holden acquired 2,720 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was acquired at an average cost of $55.31 per share, for a total transaction of $150,443.20. Following the transaction, the director now directly owns 9,224 shares in the company, valued at $510,179.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gregory T. Lucier acquired 10,000 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were bought at an average price of $53.60 per share, with a total value of $536,000.00. Following the completion of the transaction, the director now owns 10,000 shares in the company, valued at $536,000. The disclosure for this purchase can be found here. Insiders bought a total of 22,720 shares of company stock valued at $1,223,243 over the last 90 days. Corporate insiders own 0.62% of the company’s stock.

Shares of NASDAQ:XRAY traded up $0.12 during midday trading on Friday, hitting $52.39. The stock had a trading volume of 36,619 shares, compared to its average volume of 1,887,837. The company’s 50-day moving average price is $55.66 and its 200-day moving average price is $51.78. The company has a market capitalization of $11.96 billion, a P/E ratio of 26.07, a price-to-earnings-growth ratio of 1.95 and a beta of 0.97. The company has a quick ratio of 1.39, a current ratio of 2.08 and a debt-to-equity ratio of 0.30. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $59.40.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 EPS for the quarter, beating the consensus estimate of $0.62 by $0.04. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1.04 billion. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. The business’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.60 EPS. Research analysts expect that DENTSPLY SIRONA Inc will post 2.39 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Hold Rating

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.